Xencor Inc
F:XE9

Watchlist Manager
Xencor Inc Logo
Xencor Inc
F:XE9
Watchlist
Price: 13.1 EUR 1.55% Market Closed
Market Cap: 807.4m EUR

Wall Street
Price Targets

XE9 Price Targets Summary
Xencor Inc

Wall Street analysts forecast XE9 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XE9 is 24.8 EUR with a low forecast of 14.78 EUR and a high forecast of 37.96 EUR.

Lowest
Price Target
14.78 EUR
13% Upside
Average
Price Target
24.8 EUR
89% Upside
Highest
Price Target
37.96 EUR
190% Upside
Xencor Inc Competitors:
Price Targets
CELC
Celcuity Inc
11% Upside
ASND
Ascendis Pharma A/S
29% Upside
688363
Bloomage Biotechnology Corp Ltd
10% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
29% Upside
RARE
Ultragenyx Pharmaceutical Inc
338% Upside
FYB
Formycon AG
96% Upside
REGN
Regeneron Pharmaceuticals Inc
4% Upside
688105
Nanjing Vazyme Biotech Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
Xencor Inc

For the last 12 years the compound annual growth rate for Xencor Inc's revenue is 23%. The projected CAGR for the next 4 years is 13%.

23%
Past Growth
13%
Estimated Growth
Estimates Accuracy
19%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Xencor Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Net Income
Forecast

Net Income Estimate
Xencor Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XE9's stock price target?
Price Target
24.8 EUR

According to Wall Street analysts, the average 1-year price target for XE9 is 24.8 EUR with a low forecast of 14.78 EUR and a high forecast of 37.96 EUR.

What is Xencor Inc's Revenue forecast?
Projected CAGR
13%

For the last 12 years the compound annual growth rate for Xencor Inc's revenue is 23%. The projected CAGR for the next 4 years is 13%.

Back to Top